<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02033577</url>
  </required_header>
  <id_info>
    <org_study_id>NCT01514799</org_study_id>
    <nct_id>NCT02033577</nct_id>
  </id_info>
  <brief_title>Effects of Long Biliopancreatic Limb Versus Long Alimentary Limb in Superobesity, a Randomized Study</brief_title>
  <acronym>BMI&gt;50</acronym>
  <official_title>Effects of Long Biliopancreatic Limb vs Long Alimentary Limb in Superobesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aleris Obesity</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lund University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aleris Obesity</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgical bypassing of a longer section of the small bowel (when doing a gastric bypass
      operation) gives better results on body weight in the superobese. We do not yet know whether
      it is beneficial to exclude more of the proximal small bowel or more of the distal. Side
      effects of bypassing can also be different.

      Study aims at clarifying possible differences in effects and side-effects of these two
      surgical-technical variations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomisation in the OR between long biliopancreatic limb and long alimentary limb. GAstric
      component identical.

      Perioperative biopsies to assess mucosal properties at the gastrojejunostomy and the
      enteroanastomosis. Repeat biopsies (gastroscopy) at one year to identify changes in the
      mucosa at the Gastroenteroanastomosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight reduction</measure>
    <time_frame>2 years from end of inclusion</time_frame>
    <description>Body weight reduction is currently the best substitute endpoint to correlate with the hard endpopints such as death, comorbidities etc.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient assessed quality of life</measure>
    <time_frame>2 years from end of inclusion</time_frame>
    <description>We employ SF-36, Op-9, GSRS, TFEQ scales</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Short-term complications</measure>
    <time_frame>0-30 days postoperatively</time_frame>
    <description>Time to discharge, leaks, bleeding</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Severe Obesity</condition>
  <arm_group>
    <arm_group_label>Distal gastrojejunal bypass</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>RYGB with 200 cm BP limb and 150 cm common limb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RYGB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>RYGB with 60 cm BP limb and 150 cm alimentary limb</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Distal gastrojejunal bypass</intervention_name>
    <description>RYGB with 200 cm BP limb and 150 cm common limb, effect on EWL, QoL and complications</description>
    <arm_group_label>Distal gastrojejunal bypass</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>RYGB</intervention_name>
    <description>RYGB with 60 cm BP limb and 150 cm alimentary limb, effect on</description>
    <arm_group_label>RYGB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &gt; 50

        Exclusion Criteria:

          -  Psychiatric disease

          -  Inflammatory bowel disease

          -  inability to understand Swedish
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jan Hedenbro, MD,PhD</last_name>
    <phone>+46705132572</phone>
    <email>jan.hedenbro@aleris.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hjortur G Gislason, MD,PhD</last_name>
    <phone>+4748891375</phone>
    <email>hjortur.gislason@aleris.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aleris Obesity</name>
      <address>
        <city>Lund</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bent Johnny Nergaard, MD</last_name>
      <phone>+4792861730</phone>
      <email>bjnergard@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Jan Hedenbro</last_name>
    </contact_backup>
    <investigator>
      <last_name>Bent Johnny Nergaard, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2014</study_first_submitted>
  <study_first_submitted_qc>January 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2014</study_first_posted>
  <last_update_submitted>March 16, 2015</last_update_submitted>
  <last_update_submitted_qc>March 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aleris Obesity</investigator_affiliation>
    <investigator_full_name>Jan Hedenbro</investigator_full_name>
    <investigator_title>Senior scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

